Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
Objective: The aim of the present study was to compare patients with ankylosing spondylitis (AS) with healthy controls with respect to subclinical atherosclerotic cardiovascular disease (CVD). Methods: A total of 44 patients with AS with no history of CVD, diabetes mellitus, hypertension, chronic ki...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2019-09-01
|
| Series: | Anatolian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-13367 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850238205562978304 |
|---|---|
| author | Erdinç Hatipsoylu İlker Şengül Taciser Kaya Altınay Göksel Karatepe Seniz Akçay Leyla Isayeva Giray Bozkaya Erhan Tatar |
| author_facet | Erdinç Hatipsoylu İlker Şengül Taciser Kaya Altınay Göksel Karatepe Seniz Akçay Leyla Isayeva Giray Bozkaya Erhan Tatar |
| author_sort | Erdinç Hatipsoylu |
| collection | DOAJ |
| description | Objective: The aim of the present study was to compare patients with ankylosing spondylitis (AS) with healthy controls with respect to subclinical atherosclerotic cardiovascular disease (CVD).
Methods: A total of 44 patients with AS with no history of CVD, diabetes mellitus, hypertension, chronic kidney disease, and lipid-lowering drug use were compared with 40 age- and sex-matched healthy controls with respect to carotid intima-media thickness (CIMT) and pulse wave velocity (PWV), which are surrogate markers of subclinical atherosclerosis. Correlation analysis was also performed to examine the association between surrogate markers and disease activity with inflammation [Ankylosing spondylitis disease activity score with C-reactive protein (ASDAS-CRP)].
Results: In addition to age and sex, both groups were comparable with respect to cigarette smoking, body mass index, and high-density lipoprotein cholesterol (p=0.425, p=0.325, and p=0.103, respectively). The level of total cholesterol was significantly lower in patients with AS (p=0.002). Nonsteroidal anti-inflammatory drug and tumor necrosis factor alpha inhibitor use ratios in patients with AS were 79.5% and 65.9%, respectively. There was no significant difference between both groups regarding PWV and CIMT (p=0.788 and p=0.253, respectively). In patients with AS, there was a significant correlation between ASDAS-CRP and CIMT (r=0.315, p=0.038), but the correlation between ASDAS-CRP and PWV was not significant (r=−0.183, p=0.234).
Conclusion: The results of the present study could not provide sufficient evidence whether disease activity with inflammation caused subclinical atherosclerotic CVD in patients with AS without overt CVD. The increased atherosclerotic CVD risk is most probably multifactorial in patients with AS, but the extent of the contribution of disease activity with inflammation to increased atherosclerosis is controversial. |
| format | Article |
| id | doaj-art-2b5a83e2595d4d0ab9b2a0a2bb12c43e |
| institution | OA Journals |
| issn | 2149-2263 |
| language | English |
| publishDate | 2019-09-01 |
| publisher | KARE Publishing |
| record_format | Article |
| series | Anatolian Journal of Cardiology |
| spelling | doaj-art-2b5a83e2595d4d0ab9b2a0a2bb12c43e2025-08-20T02:01:33ZengKARE PublishingAnatolian Journal of Cardiology2149-22632019-09-0122418519110.14744/AnatolJCardiol.2019.13367AJC-13367Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitisErdinç Hatipsoylu0İlker Şengül1Taciser Kaya2Altınay Göksel Karatepe3Seniz Akçay4Leyla Isayeva5Giray Bozkaya6Erhan Tatar7Department of Physical Medicine and Rehabilitation, Kahramanmaraş Afşin State Hospital; Kahramanmaraş-TurkeyDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-TurkeyDepartment of Physical Medicine and Rehabilitation, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyDepartment of Physical Medicine and Rehabilitation, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyDepartment of Physical Medicine and Rehabilitation, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyDepartment of Radiology, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyDepartment of Biochemistry, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyDepartment of Nephrology, İzmir Bozyaka Training and Research Hospital of University of Health Sciences, İzmir, TurkeyObjective: The aim of the present study was to compare patients with ankylosing spondylitis (AS) with healthy controls with respect to subclinical atherosclerotic cardiovascular disease (CVD). Methods: A total of 44 patients with AS with no history of CVD, diabetes mellitus, hypertension, chronic kidney disease, and lipid-lowering drug use were compared with 40 age- and sex-matched healthy controls with respect to carotid intima-media thickness (CIMT) and pulse wave velocity (PWV), which are surrogate markers of subclinical atherosclerosis. Correlation analysis was also performed to examine the association between surrogate markers and disease activity with inflammation [Ankylosing spondylitis disease activity score with C-reactive protein (ASDAS-CRP)]. Results: In addition to age and sex, both groups were comparable with respect to cigarette smoking, body mass index, and high-density lipoprotein cholesterol (p=0.425, p=0.325, and p=0.103, respectively). The level of total cholesterol was significantly lower in patients with AS (p=0.002). Nonsteroidal anti-inflammatory drug and tumor necrosis factor alpha inhibitor use ratios in patients with AS were 79.5% and 65.9%, respectively. There was no significant difference between both groups regarding PWV and CIMT (p=0.788 and p=0.253, respectively). In patients with AS, there was a significant correlation between ASDAS-CRP and CIMT (r=0.315, p=0.038), but the correlation between ASDAS-CRP and PWV was not significant (r=−0.183, p=0.234). Conclusion: The results of the present study could not provide sufficient evidence whether disease activity with inflammation caused subclinical atherosclerotic CVD in patients with AS without overt CVD. The increased atherosclerotic CVD risk is most probably multifactorial in patients with AS, but the extent of the contribution of disease activity with inflammation to increased atherosclerosis is controversial.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-13367ankylosing spondylitiscarotid intima-media thicknesspulse wave velocitysubclinical cardiovascular disease |
| spellingShingle | Erdinç Hatipsoylu İlker Şengül Taciser Kaya Altınay Göksel Karatepe Seniz Akçay Leyla Isayeva Giray Bozkaya Erhan Tatar Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis Anatolian Journal of Cardiology ankylosing spondylitis carotid intima-media thickness pulse wave velocity subclinical cardiovascular disease |
| title | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| title_full | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| title_fullStr | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| title_full_unstemmed | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| title_short | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| title_sort | assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
| topic | ankylosing spondylitis carotid intima-media thickness pulse wave velocity subclinical cardiovascular disease |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-13367 |
| work_keys_str_mv | AT erdinchatipsoylu assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT ilkersengul assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT taciserkaya assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT altınaygokselkaratepe assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT senizakcay assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT leylaisayeva assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT giraybozkaya assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis AT erhantatar assessmentofsubclinicalatheroscleroticcardiovasculardiseaseinpatientswithankylosingspondylitis |